No abstract available
MeSH terms
-
Cancer Vaccines / therapeutic use*
-
Clinical Trials, Phase II as Topic
-
Humans
-
Male
-
Middle Aged
-
Prognosis
-
Prostate-Specific Antigen / blood*
-
Prostatic Neoplasms / blood*
-
Prostatic Neoplasms / drug therapy*
-
Prostatic Neoplasms / immunology
Substances
-
Cancer Vaccines
-
Prostate-Specific Antigen